EUnetHTA prioritises topics for Joint Assessments
EUnetHTA publishes the EUnetHTA Prioritisation List (EPL) Find the EPL HERE The EPL expresses the identified significant interest of national HTA bodies in relation to individual compounds as presented in the list. By pro-actively selecting those topics in direct collaboration with national bodies, EUnetHTA strives to increase implementation of Joint Assessments qualitatively and quantitatively at […]
Patient group consultation now open: medical product for high-risk soft tissue sarcoma treatment
Find public consultation HERE
EUnetHTA Magazine: Fall 2018
HTA proposal: update; HTA reports; Impact: Italy; Interview: EP Rapporteur: Soledad Cabezón Ruiz MEP; Partner Profile: AIFA; Senior Science Officer: Giovanni Tafuri; working together: HTA Network Stakeholder Pool Downloadable PDF HERE [pdf-embedder url=”https://www.eunethta.eu/wp-content/uploads/2018/10/Fall_2018_Magazine-2.pdf” title=”Fall_2018_Magazine (2)”]
What’s in it for us? Benefits of European HTA Non-Duplication
“HTA cooperation produces and will produce very tangible benefits not only for patients, but also improve the quality and sustainability of health systems when Europe needs them most.” [vc_row][vc_column][vc_single_image image=”15600″ img_size=”large”][vc_column_text] [pdf-embedder url=”https://www.eunethta.eu/wp-content/uploads/2018/09/Summer_2018_Magazine-2-Photos-Sidebar-and-1-Column.pdf” title=”Summer_2018_Magazine – 2 Photos, Sidebar, and 1 Column”][/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row]
EUnetHTA Magazine – Summer 2018
EUnetHTA Magazine – Summer 2018 HERE HTA Proposal: Is It Lights Out?; HTA reports; Impact: Lithuania; Interview: EURORDIS; Partner Profile: Poland; Non-Duplication: What’s in it for us? [pdf-embedder url=”https://www.eunethta.eu/wp-content/uploads/2018/09/summer_2018_magazine_digital_FINAL-1.pdf” title=”summer_2018_magazine_digital_FINAL”]
OTCA16 Bioresorbable Stents in cardiovascular indications (coronary artery disease) Project Plan Now Available
The final project plan of the assessment on “Bioresorbable Stents in cardiovascular indications (coronary artery disease)” and the comments provided by the external experts and the manufacturers are now available. OTCA16 Project Plan HERE OTCA16 External Expert and Manufacturer Comments HERE
The Joint Assessment, OTJA08, on “Continuous glucose monitoring (CGM real-time) and flash glucose monitoring (FGM) as personal, standalone systems in patients with diabetes mellitus treated with insulin” is now available.
We are pleased to announce that the joint rapid assessment on “Continuous glucose monitoring (CGM real-time) and flash glucose monitoring (FGM) as personal, standalone systems in patients with diabetes mellitus treated with insulin” is available. The health technologies assessed include rtCGM systems and FGM systems as personal, standalone medical devices for patients with diabetes mellitus […]
OTJA10 “Stool DNA testing for early detection of colorectal cancer” Final Project Plan Now Available
[vc_row][vc_column][vc_column_text]This is the final project plan of the assessment on Stool DNA testing for early detection of colorectal cancer. Download Final Project Plan HERE Download summary of comments received from external review, including the authors’ answers HERE [pdf-embedder url=”https://www.eunethta.eu/wp-content/uploads/2018/07/OTJA10_Project-Plan__final.pdf” title=”OTJA10_Project Plan__final”][/vc_column_text][/vc_column][/vc_row]
OTCA14 “Robotic surgery in thoracic and visceral indications” Final Project Plan and Combined Comments Now Available
This is the final project plan of the assessment on robotic surgery in thoracic and visceral indications. The combined comments from external experts and the manufacturer fact check with authors’ replies are also available. Download the final project plan HERE Download the combined comments and fact check HERE [pdf-embedder url=”https://www.eunethta.eu/wp-content/uploads/2018/07/Project-Plan_OTCA14.pdf” title=”Project Plan_OTCA14″] [pdf-embedder url=”https://www.eunethta.eu/wp-content/uploads/2019/05/Combined-comments-from-external-experts-and-manufacturer-fact-check-with-authors-replies-OTCA14.pdf” title=”Project […]
Patient group input requested for a new Joint Assessment on a medicinal product for Diabetes Type 1 – Closing August 3
EUnetHTA Joint Production is pleased to announce the launch of the REA for Sotagliflozin for Type 1 diabetes mellitus (PTJA04) For this specific assessment on a medicinal product for Diabetes Type 1, an ‘open call for patient group submission‘ is used. We are seeking for European and national patient organisations to provide an organisational perspective […]
